PF4 Antibody Persistence and Long-term Pathogenicity in VITT
Anand Padmanabhan, Professor and Consultant at Mayo Clinic, shared on LinkedIn:
”Congrats to Adam Kanack, Emily Mauch, Guillaume Roberge, and coauthors related to their study on long-term persistence and pathogenicity of VITT antibodies.
Key points:
– Despite clonal restriction of Anti-PF4 abs in VITT, unlike MGTS, these monoclonal spikes are not seen when the entire IgG repertoire is examined. You unmask anti-PF4 clonal restriction only when you isolate the anti-PF4 antibodies
– In some cases, VITT abs can comprise kappa light chains (dogma to date is that it can only be lambda)
– As shown in a case in our report, thrombocytopenia can persist for more than 4 years.”
Read the full article here.
Title: Platelet Factor 4 Antibody Persistence and Long-term Pathogenicity in Vaccine-induced Immune Thrombotic Thrombocytopenia
Authors: Adam Kanack, Emily Mauch, Guillaume Roberge, Noah Splinter, Krishna Gundabolu, Geoffrey D. Wool, Gemlyn George, Mouhamed Yazan Abou-Ismail, Kristi J. Smock, David L. Green, Jonathan Coker, Mindy C. Kohlhagen, David L. Murray, Anand Padmanabhan
Keep up with Hemostasis Today.
-
Oct 17, 2026, 09:33Robert Lookstein: Mechanical Thrombectomy Shows Functional Benefits in Intermediate-High-Risk PE
-
Oct 17, 2026, 09:18Sarra Hmidi: Tunisia Highlights Thrombosis Prevention on World Thrombosis Day
-
Oct 17, 2026, 09:05Addressing the Hidden Burden of Bleeding Disorders in Women – Hemophilia Society Mumbai Chapter
-
Oct 17, 2026, 08:49Maria Magnusson: Karolinska Experts Explore Gene Therapy in Sickle Cell Disease and Hemophilia
-
Oct 17, 2026, 04:07Weihao Li: Global HEPATIC Registry Findings on Post-Transplant Arterial Thrombosis
-
Oct 17, 2026, 03:56Ghaith Abu-Zeinah: ASH Publishes 2026 Guidelines for Myelofibrosis Management in Blood Advances
-
Oct 17, 2026, 03:48Tristan Siokos: Why Vascular Occlusion Is More Than Just Clots – Breakdown of the 8 Pathways
-
Oct 17, 2026, 02:36Archil Jaliashvili: Oxygen Transport in Capillaries
-
Oct 17, 2026, 02:35Carly Newton: Understanding Access to Red Blood Cell Exchange for People Living With SCD